Description
The Medics Autonomously Stopping Hemorrhage (MASH) program aims to develop autonomous systems for stabilizing torso hemorrhage without the need for a surgeon in forward medical sites, providing 48+ hours to reach definitive care. The program seeks approaches that merge multi-modal automated bleed detection and localization with automated, minimally invasive robotic end effectors and sensors. Key aspects of the program include:
• Developing demonstrator autonomous systems for pre-hospital hemorrhage control
• Pushing the standard of pre-hospital hemorrhage control to 48 hours
• Stopping lethal forms of torso hemorrhage without a surgeon
• Providing minimally invasive surgery (MIS) a path to enter the trauma market and utilize full autonomy
The program's vision is to revolutionize the standard of pre-hospital hemorrhage control and provide a new approach to trauma care.